545 related articles for article (PubMed ID: 10646820)
1. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.
Kenter GG; Hellebrekers BW; Zwinderman KH; van de Vijver M; Peters LA; Trimbos JB
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):72-6. PubMed ID: 10646820
[TBL] [Abstract][Full Text] [Related]
2. [Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence].
Hellebrekers BW; Zwinderman AH; Kenter GG; Peters AA; Fleuren GJ; Trimbos JB
Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2304-9. PubMed ID: 11143298
[TBL] [Abstract][Full Text] [Related]
3. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
5. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
7. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB
Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845
[TBL] [Abstract][Full Text] [Related]
8. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
9. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
10. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
11. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
13. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
14. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ;
Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
[TBL] [Abstract][Full Text] [Related]
16. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
17. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
18. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
19. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
